Based on the assumption that WT cells would have a competitive advantage over Mesp1-KO cells, we hypothesized that creating chimeric mice with both Mesp1-KO and WT cells would generate hearts that are fully comprised of WT cells, offering an ideal outcome for the BC method. The gene discussed is MESP1; the disease is breast cancer.